References
- Ando H, Nishio Y, Ito K, Nakao A, Wang L, Zhao YL, Kitaichi K, Takagi K, Hasegawa T. Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats. Antimicrobial Agents and Chemotherapy 2001; 45: 3462–3467
- Annaert PP, Brouwer KL. Assessment of drug interactions in hepatobiliary transport using rhodamine 123 in sandwich-cultured rat hepatocytes. Drug Metabolism and Disposition 2005; 33: 388–394
- Brouwer KL, Thurman RG. Isolated perfused liver. Pharmaceutical Biotechnology 1996; 8: 161–192
- Jager W, Winter O, Halper B, Salamon A, Sartori M, Gajdzik L, Hamilton G, Theyer G, Graf J, Thalhammer T. Modulation of liver canalicular transport processes by the tyrosine-kinase inhibitor genistein: Implications of genistein metabolism in the rat. Hepatology 1997; 26: 1467–1476
- Johnson LV, Walsh ML, Bockus BJ, Chen LB. Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy. Journal of Cellular Biology 1981; 88: 526–535
- Johnson LV, Walsh ML, Chen LB. Localization of mitochondria in living cells with rhodamine 123. Proceedings of the National Academy of Sciences, USA 1980; 77: 990–994
- Mehvar R, Zhang XP. Development and application of an isolated perfused rat liver model to study the stimulation and inhibition of tumor necrosis factor — a production ex vivo. Pharmaceutical Research 2002; 19: 47–53
- National Research Council. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC 1996
- Naud J, Michaud J, Leblond FA, Lefrancois S, Bonnardeaux A, Pichette V. Effects of chronic renal failure on liver drug transporters. Drug Metabolism and Disposition 2008; 36: 124–128
- Pang KS. Liver perfusion studies in drug metabolism and drug toxicity. Drug metabolism and drug toxicity, JR Mitchell, MG Horning. Raven, New York, NY 1984; 331–352
- Piquette-Miller M, Pak A, Kim H, Anari R, Shahzamani A. Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation. Pharmaceutical Research 1998; 15: 706–711
- Stapf V, Thalhammer T, Huber-Huber R, Felberbauer F, Gajdzik L, Graf J. Inhibition of rhodamine 123 secretion by cyclosporin A as a model of P-glycoprotein mediated transport in liver. Anticancer Research 1994; 14: 581–585
- Sweatman TW, Seshadri R, Israel M. Metabolism and elimination of rhodamine 123 in the rat. Cancer Chemotherapy and Pharmacology 1990; 27: 205–210
- Turncliff RZ, Meier PJ, Brouwer KL. Effect of dexamethasone treatment on the expression and function of transport proteins in sandwich-cultured rat hepatocytes. Drug Metabolism and Disposition 2004; 32: 834–839
- Vuppugalla R, Mehvar R. Short-term inhibitory effects of nitric oxide on cytochrome P450-mediated drug metabolism: Time dependency and reversibility profiles in isolated perfused rat livers. Drug Metabolism and Disposition 2004; 32: 1446–1454
- Yumoto R, Murakami T, Sanemasa M, Nasu R, Nagai J, Takano M. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone. Drug Metabolism and Disposition 2001; 29: 145–151